Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.
about
Olfactory Receptors in Non-Chemosensory Organs: The Nervous System in Health and DiseaseUtility of susceptibility-weighted imaging in Parkinson's disease and atypical Parkinsonian disordersParkinson's disease as a result of agingParkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expressionFear potentiated startle increases phospholipase D (PLD) expression/activity and PLD-linked metabotropic glutamate receptor mediated post-tetanic potentiation in rat amygdala.Dopamine D1 and D2 receptor antagonism effects on rat ultrasonic vocalizations.Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.First neuropathological description of a patient with Parkinson's disease and LRRK2 p.N1437H mutationOn the Relationship between Energy Metabolism, Proteostasis, Aging and Parkinson's Disease: Possible Causative Role of Methylglyoxal and Alleviative Potential of Carnosine.Proteomic identification of aldolase A as an autoantibody target in patients with atypical movement disorders.Gene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation.Evaluation of Parkinson disease risk variants as expression-QTLs.Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutationComplex network-driven view of genomic mechanisms underlying Parkinson's disease: analyses in dorsal motor vagal nucleus, locus coeruleus, and substantia nigraRotigotine transdermal patch in Parkinson's disease: a systematic review and meta-analysis.Construction and analysis of the protein-protein interaction networks based on gene expression profiles of Parkinson's disease.Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?Gastrointestinal Autonomic Dysfunction in Patients with Parkinson's Disease.Imaging changes associated with cognitive abnormalities in Parkinson's diseaseParkinson disease and incidental Lewy body disease: Just a question of time?Altered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson's disease.Premotor biomarkers for Parkinson's disease - a promising direction of research.MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein.microRNA Profiles in Parkinson's Disease Prefrontal CortexMelatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation.Dopamine prevents lipid peroxidation-induced accumulation of toxic α-synuclein oligomers by preserving autophagy-lysosomal function.Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer's and Parkinson's DiseasesHigh-dose thiamine as initial treatment for Parkinson's diseaseA mitochondrial location for haemoglobins--dynamic distribution in ageing and Parkinson's diseaseProspects for cannabinoid therapies in basal ganglia disorders.Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.Brain banks as key part of biochemical and molecular studies on cerebral cortex involvement in Parkinson's disease.Current understanding of the glial response to disorders of the aging CNS.Mitochondrial dynamics: the intersection of form and function.Developmental neuroplasticity and the origin of neurodegenerative diseases.α-Synuclein in the olfactory system in Parkinson's disease: role of neural connections on spreading pathology.Mass spectrometry and redox proteomics: applications in disease.α-Synuclein promotes clathrin-mediated NMDA receptor endocytosis and attenuates NMDA-induced dopaminergic cell death.Neuropathobiology of non-motor symptoms in Parkinson disease.Longitudinal changes of cortical microstructure in Parkinson's disease assessed with T1 relaxometry
P2860
Q26741605-96FBD549-8F98-415A-ABDB-8C11F9C45BACQ28066787-BC378FAF-DB97-4C50-9354-FDDC96048BBCQ28084395-F33FF1C4-A410-406A-A9B6-E3265D4ED23EQ28598223-B539FA29-939A-44B9-9AAA-59FEFF89429AQ30364663-912A5087-5AE8-4D31-964E-86129A7F68FEQ30431683-9B25009B-7235-4D44-AC38-E0BA9870D131Q30446460-741B9A7F-8ACF-4AF8-99AE-C27D22F2483FQ30513503-63839153-CA46-4C28-B18D-E2DE5A2FDDF8Q33714263-93D2EE32-5642-405E-A049-185B6EF33CC6Q34185195-06FD9772-8B35-4A2D-A4E2-66D0AB004FE7Q34325576-31B449AC-52CD-403D-8B7B-D1F2348A1C28Q34446993-C56CD70E-327E-4EFD-BA52-1DA5BEBFB23AQ34555995-BFCE0BD3-A879-4024-BBE3-134F77A12833Q34667486-8D88F098-6E1E-4048-A28A-17533EEC73CFQ34921068-FCF860BF-4688-4E25-9F19-596ED2EA17C2Q35234940-59C60860-64A7-4F44-8947-B78FED7A65CAQ35412397-DA36CDEB-4964-40FC-8246-8DE4E0A27CDDQ35699782-7FE5A6C1-A3F4-44FA-B4FD-A44A160E505EQ35797763-4921DAF1-B9BF-4209-A621-F134803A27B5Q36300086-B1AB2716-D509-44DE-B9F6-6881063C0143Q36336723-24E5E55E-512A-48B7-8658-C3FDC219D6CDQ36444517-0BC934A0-E81E-4E8C-AEE1-E590DFC1D25FQ36525872-736AD8F1-0B72-41DB-891C-5CCA53B115FDQ36634755-4C41DF8A-AB99-4BC9-99FF-4ED22E0828FEQ36777303-DF098119-1F41-42DC-84C3-FE2BC15155ABQ36888986-029452AB-9FB7-43FA-8569-0910F9F67B89Q37053721-87E0CA64-F4FF-42F9-8BD5-0E0AEEBC1D22Q37145679-34B800BB-D9AB-4CD4-80C6-6698B6BAABD4Q37671549-B79B40EF-5BC3-4E30-A596-0AB4C52E4F20Q37872326-5BF2CFD9-B908-4F6B-A87A-428B696D4D52Q37955871-2AE80518-5EA9-4392-B4A9-441ACED16D0FQ37982151-66C9BF4B-D93A-47E2-9037-285D2E0FF67CQ38015354-5D3DFBA7-BA7C-40BC-BBCE-A9FB64811AC8Q38021396-F6BCB757-3584-4A57-9007-A09FE007DB6EQ38109214-29600096-62A6-488E-9CA2-13D1C58E4769Q38153587-6EFC7D11-5624-435C-867B-96A50D885F2EQ38220377-FB2BE488-2ADC-4C9F-80BD-097930C53F9EQ38332283-5EEFFF9E-383D-46D4-96F5-E60ABC54292AQ38481481-9BC3AA26-FC0B-46D6-B1D0-AD7DE494A1CAQ38766599-B967F677-E05B-4FFE-A4A5-5F14FF5EEFE8
P2860
Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuropathology of sporadic Par ...... preclinical Parkinson disease.
@en
Neuropathology of sporadic Par ...... preclinical Parkinson disease.
@nl
type
label
Neuropathology of sporadic Par ...... preclinical Parkinson disease.
@en
Neuropathology of sporadic Par ...... preclinical Parkinson disease.
@nl
prefLabel
Neuropathology of sporadic Par ...... preclinical Parkinson disease.
@en
Neuropathology of sporadic Par ...... preclinical Parkinson disease.
@nl
P2093
P2860
P1476
Neuropathology of sporadic Par ...... preclinical Parkinson disease.
@en
P2093
Anna Martinez
Ester Dalfó
Isidre Ferrer
Margarita Carmona
Rosa Blanco
P2860
P2888
P304
P356
10.1007/S00702-010-0482-8
P577
2010-09-23T00:00:00Z